tirzepatide vs semaglutide español vs. Semaglutide: Which is Best for Weight Loss? Semaglutide vs. Tirzepatide: Which GLP-1

increases hypoglycaemia risk when combined with insulin or sulfonylureas Cardiovascular health Emerging evidence suggests cardiovascular benefits associated with significant weight loss and improved metabolic markers Long-term cardiovascular outcome data for tirzepatide specifically is still accumulating compared with older GLP-1 agents Gastrointestinal side effects Typically mild to moderate and temporary, particularly during dose escalation

These numbers represent clinical trial averages under controlled conditions with regular monitoring and support

Simply enter your HSA/FSA card information at checkout as you would any debit or credit card

Who Might Prefer Semaglutide

Mild nausea, fatigue, or constipation occur in 20 to 30 percent of patients and typically resolve within 5 to 6 days

Others report a plateau effect, where an initial improvement in migraines levels off or reverses